← Leaderboards
Peter Palese
Icahn School Of Medicine At Mount Sinai
$9,716,912
Attributed
$9,716,912
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $7M · FY2009–16$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$9,716,912 · 2
By mechanism
N01$9,715,724 · 2
N02$1,188 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Darrell J Irvine$37,519,809
- Ana Fernandez-Sesma$24,867,465
- Balaji Manicassamy$10,074,679
- Florian Krammer$130,401,178
- Carolina B. Lopez$11,911,530
Others in their field
Top investigators on “Animal Model”
- David Heimbrook · Leidos Biomedical Research, Inc.$464,525,875
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Joseph E Robertson · Oregon Health & Science University$126,125,279
- Peter Gordon Gillespie · Oregon Health And Science University$105,808,119
- David M Anderson · University Of Washington$102,920,737
- Polly Chang · Sri International$84,271,267
Research focus
Animal ModelCommunicable DiseasesContractsStandardizationEfficacy TestingMouse ModelAntiviral AgentsMeetingsProgramsTherapeutic VaccineEvaluationMiddle East Respiratory Syndrome CoronavirusAnimal Model DevelopmentChikungunyaCell TypeImmunotherapeutic AgentCell Mediated Immune ResponseAvian InfluenzaImmunologic AdjuvantsB-LymphocytesImmune SystemImmunologic ReceptorsHigh Throughput ScreeningBirds
Grant awards (8)
Task A57:MOUSE MODEL FOR EVALUATION OF COUNTERMEASURES AGAINST MERS$169,392
N01 · FY2016 · AI · contact PI
Collaborative Antiviral Testing Group Annual Meeting$1,425
N01 · FY2016 · AI · contact PI
Task A57:MOUSE MODEL FOR EVALUATION OF COUNTERMEASURES AGAINST MERS$168,705
N01 · FY2015 · AI · contact PI
Task A86: Mouse Models for Evaluation of Therapeutics against Human Seasonal Influenza and Avian Influenza Strains with Pandemic Potential$58,686
N01 · FY2015 · AI · contact PI
Animal Models of Infectious Diseases - Collaborative Antiviral Testing Group$1,188
N02 · FY2014 · AI · contact PI
Interferon-inducing compounds for use as broad antivirals/adjuvants$1,881,355
N01 · FY2013 · AI · contact PI
Task A26: Mouse Model for Chikungunya$399,266
N01 · FY2011 · AI · contact PI
Interferon-inducing compounds for use as broad antivirals/adjuvants$7,036,895
N01 · FY2009 · AI · contact PI